PortfoliosLab logoPortfoliosLab logo
SBIO vs. FHLC
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

SBIO vs. FHLC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ALPS Medical Breakthroughs ETF (SBIO) and Fidelity MSCI Health Care Index ETF (FHLC). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SBIO achieves a 18.79% return, which is significantly higher than FHLC's 1.10% return. Over the past 10 years, SBIO has outperformed FHLC with an annualized return of 11.54%, while FHLC has yielded a comparatively lower 10.13% annualized return.


SBIO

1D
2.88%
1M
14.15%
YTD
18.79%
6M
15.02%
1Y
98.14%
3Y*
25.22%
5Y*
4.73%
10Y*
11.54%

FHLC

1D
0.99%
1M
3.71%
YTD
1.10%
6M
0.13%
1Y
19.01%
3Y*
7.41%
5Y*
4.66%
10Y*
10.13%
*Multi-year figures are annualized to reflect compound growth (CAGR)

SBIO vs. FHLC - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
SBIO
ALPS Medical Breakthroughs ETF
18.79%55.07%3.81%8.68%-28.08%-17.55%21.17%50.30%-11.81%45.67%
FHLC
Fidelity MSCI Health Care Index ETF
1.10%15.42%2.48%2.58%-5.55%20.39%18.13%21.94%4.71%23.34%

Correlation

The correlation between SBIO and FHLC is 0.53, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.53

Correlation (3Y)
Calculated over the trailing 3-year period

0.55

Correlation (5Y)
Calculated over the trailing 5-year period

0.58

Correlation (10Y)
Calculated over the trailing 10-year period

0.63

Correlation (All Time)
Calculated using the full available price history since Dec 31, 2014

0.66

The correlation between SBIO and FHLC shifts across timeframes, from 0.53 (1 year) to 0.66 (all time), reflecting how their relationship changes across market environments.

SBIO vs. FHLC - Sectors Allocation Comparison


Sectors
SBIO
FHLC

Healthcare

100.0%
99.7%

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Industrials

-

0.0%

Real Estate

-

-

Technology

-

0.0%

Utilities

-

-

Financial Services

-0.0%
0.0%

Healthcare

SBIO
100.0%
FHLC
99.7%

Basic Materials

SBIO

-

FHLC

-

Communication Services

SBIO

-

FHLC

-

Consumer Cyclical

SBIO

-

FHLC

-

Consumer Defensive

SBIO

-

FHLC

-

Energy

SBIO

-

FHLC

-

Industrials

SBIO

-

FHLC
0.0%

Real Estate

SBIO

-

FHLC

-

Technology

SBIO

-

FHLC
0.0%

Utilities

SBIO

-

FHLC

-

Financial Services

SBIO
-0.0%
FHLC
0.0%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SBIO vs. FHLC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SBIO
SBIO Risk / Return Rank: 9393
Overall Rank
SBIO Sharpe Ratio Rank: 9595
Sharpe Ratio Rank
SBIO Sortino Ratio Rank: 9393
Sortino Ratio Rank
SBIO Omega Ratio Rank: 8888
Omega Ratio Rank
SBIO Calmar Ratio Rank: 9696
Calmar Ratio Rank
SBIO Martin Ratio Rank: 9393
Martin Ratio Rank

FHLC
FHLC Risk / Return Rank: 3939
Overall Rank
FHLC Sharpe Ratio Rank: 4040
Sharpe Ratio Rank
FHLC Sortino Ratio Rank: 4343
Sortino Ratio Rank
FHLC Omega Ratio Rank: 3737
Omega Ratio Rank
FHLC Calmar Ratio Rank: 4040
Calmar Ratio Rank
FHLC Martin Ratio Rank: 3434
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SBIO vs. FHLC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ALPS Medical Breakthroughs ETF (SBIO) and Fidelity MSCI Health Care Index ETF (FHLC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


SBIOFHLCDifference
Sharpe ratioReturn per unit of total volatility

+1.94

Sortino ratioReturn per unit of downside risk

+2.10

Omega ratioGain probability vs. loss probability

1.49

1.23

+0.26

Calmar ratioReturn relative to maximum drawdown

7.80

1.84

+5.96

Martin ratioReturn relative to average drawdown

21.75

4.54

+17.20

SBIO vs. FHLC - Sharpe Ratio Comparison

The current SBIO Sharpe Ratio is 3.24, which is higher than the FHLC Sharpe Ratio of 1.30. The chart below compares the historical Sharpe Ratios of SBIO and FHLC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

SBIO vs. FHLC - Drawdown Comparison

The maximum SBIO drawdown since its inception was -63.06%, which is greater than FHLC's maximum drawdown of -28.76%. Use the drawdown chart below to compare losses from any high point for SBIO and FHLC.


Loading charts...

Drawdown Indicators


SBIOFHLCDifference

Max Drawdown

Largest peak-to-trough decline

-63.06%

-28.76%

-34.30%

Max Drawdown (1Y)

Largest decline over 1 year

-12.66%

-10.38%

-2.28%

Max Drawdown (3Y)

Largest decline over 3 years

-42.44%

-16.87%

-25.57%

Max Drawdown (5Y)

Largest decline over 5 years

-53.10%

-17.73%

-35.37%

Max Drawdown (10Y)

Largest decline over 10 years

-63.06%

-28.76%

-34.30%

Current Drawdown

Current decline from peak

-0.77%

-2.12%

+1.35%

Average Drawdown

Average peak-to-trough decline

-28.36%

-5.19%

-23.17%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.53%

4.19%

+0.34%

Volatility

SBIO vs. FHLC - Volatility Comparison

ALPS Medical Breakthroughs ETF (SBIO) has a higher volatility of 11.21% compared to Fidelity MSCI Health Care Index ETF (FHLC) at 5.04%. This indicates that SBIO's price experiences larger fluctuations and is considered to be riskier than FHLC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SBIOFHLCDifference

Volatility (1M)

Calculated over the trailing 1-month period

11.21%

5.04%

+6.17%

Volatility (6M)

Calculated over the trailing 6-month period

23.75%

10.56%

+13.19%

Volatility (1Y)

Calculated over the trailing 1-year period

30.51%

14.76%

+15.75%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

33.76%

15.03%

+18.73%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

33.20%

16.82%

+16.38%

SBIO vs. FHLC - Expense Ratio Comparison

SBIO has a 0.50% expense ratio, which is higher than FHLC's 0.08% expense ratio.


Dividends

SBIO vs. FHLC - Dividend Comparison

SBIO has not paid dividends to shareholders, while FHLC's dividend yield for the trailing twelve months is around 1.37%.


PositionTTM20252024202320222021202020192018201720162015
FHLC
Fidelity MSCI Health Care Index ETF
1.37%1.40%1.51%1.40%1.30%1.16%1.45%1.18%1.38%1.38%1.40%2.07%
SBIO
ALPS Medical Breakthroughs ETF
0.00%0.00%3.55%0.22%0.00%0.00%0.00%0.04%2.79%1.77%0.00%0.00%

Frequently Asked Questions


SBIO and FHLC have a correlation of 0.53, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

SBIO has higher volatility (11.21%) compared to FHLC (5.04%). In terms of maximum drawdown, SBIO dropped -63.06% vs FHLC's -28.76%.

On 10-year performance, SBIO leads with 11.54% vs 10.13% for FHLC. On fees, FHLC is cheaper at 0.08% per year. On volatility, FHLC has been the lower-risk option at 5.04%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, SBIO has performed better with a 11.54% return vs 10.13%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

FHLC is cheaper with a 0.08% expense ratio, compared with 0.50% for SBIO.

FHLC has the higher dividend yield at 1.37%, compared with 0.00% for SBIO.

SBIO tracks S-Network Medical Breakthroughs Index, while FHLC tracks MSCI USA IMI Health Care Index. They also come from different issuers: SS&C and Fidelity. Their fees differ too: 0.50% for SBIO and 0.08% for FHLC.

SBIO currently has the higher Sharpe Ratio (3.24 vs 1.30), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for SBIO and FHLC

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer